Comparison of 13 acellular pertussis vaccines: adverse reactions.
about
Molecular pathogenesis, epidemiology, and clinical manifestations of respiratory infections due to Bordetella pertussis and other Bordetella subspecies.Pertussis vaccine trials in the 1990sAssociation Between Vaccine Refusal and Vaccine-Preventable Diseases in the United States: A Review of Measles and PertussisPertussis: Microbiology, Disease, Treatment, and Prevention.Re-vaccination of 421 children with a past history of an adverse vaccine reaction in a special immunisation service.Stable expression of pertussis toxin in Bordetella bronchiseptica under the control of a tightly regulated promoter.Collaborative study for the evaluation of enzyme-linked immunosorbent assays used to measure human antibodies to Bordetella pertussis antigens.Safety of a new conjugate meningococcal C vaccine in infants.Changes in Predominance of Pulsed-Field Gel Electrophoresis Profiles of Bordetella pertussis Isolates, United States, 2000-2012Protective Effect of Contemporary Pertussis Vaccines: A Systematic Review and Meta-analysis.Immunogenicity and safety of a DTaP-IPV//PRP approximately T combination vaccine given with hepatitis B vaccine: a randomized open-label trial.Pertussis vaccination in pregnancyUnraveling the challenges of pertussis.Short-Read Whole-Genome Sequencing for Laboratory-Based Surveillance of Bordetella pertussis.Eighty-kilodalton N-terminal moiety of Bordetella pertussis filamentous hemagglutinin: adherence, immunogenicity, and protective role.Safety and immunogenicity of a fully liquid vaccine containing five-component pertussis-diphtheria-tetanus-inactivated poliomyelitis-Haemophilus influenzae type b conjugate vaccines administered at two, four, six and 18 months of age
P2860
Q24522458-9BD448EC-E71F-4130-9A64-7EECD8965160Q27025393-2909093C-CFEA-408E-93B9-F645971392DAQ28078001-902A99AB-096B-44C1-95EC-CEB90A88BB19Q30251684-59422E24-D2A4-4E7E-B593-3927E53BD7A8Q33975479-149E783C-0E94-4BBC-AA25-04445B3AE94AQ35196678-792F4BB2-E988-4CD8-990B-3BC835345B00Q35228085-4E8FF698-19FB-4619-B502-DA53E8BC9AAEQ35271522-1066BCB6-8FC9-49F3-9987-07247C30C6A3Q36617112-F4A22540-9698-4B7B-B8B3-00AD1956168DQ36783198-B73E258D-848A-407B-995E-BE4588B5E6DBQ37108887-9DD2748A-0CC1-4F61-AAF8-64D3C5153357Q37197075-AB188B24-060C-40DC-A881-4C3720D7F64CQ37495317-6E4CE882-D331-40BF-9D79-64FE7DFC574BQ38947522-77E744E0-8767-4DE4-AA2F-2B39827058C7Q39656008-7D043111-A1B0-44B8-9B4E-1CB3DDD9AFEEQ41907366-94452280-3E96-4FC0-9EAF-D1D0083333A8
P2860
Comparison of 13 acellular pertussis vaccines: adverse reactions.
description
1995 nî lūn-bûn
@nan
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
1995年论文
@zh
1995年论文
@zh-cn
name
Comparison of 13 acellular pertussis vaccines: adverse reactions.
@en
type
label
Comparison of 13 acellular pertussis vaccines: adverse reactions.
@en
prefLabel
Comparison of 13 acellular pertussis vaccines: adverse reactions.
@en
P2093
P1433
P1476
Comparison of 13 acellular pertussis vaccines: adverse reactions
@en
P2093
Anderson EL
Deloria MA
Edwards KM
Englund JA
Pichichero ME
Rennels MB
Steinhoff MC
P304
P407
P433
P577
1995-09-01T00:00:00Z